PATENT CLAIM ANALYSIS

Application Number: 15774891
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-12
Patent Classification: ["514", "183000"]

Abstract:
Described herein are unit-dose formulations of 1, 1′-[1,4-phenylenebis (methylene)]-bis- 1,4,8,1 l-tetraazacyclotet-radecane (“AMD3100”) and uses thereof as an anti-fugetactic agent.

Claim (Index 6):
The kit of  claim 5 , further comprising an immune checkpoint inhibitor.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 93.0
- Lexical Diversity: 1.06897
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['11667410', '15840930', '15705631', '15672964', '14661656']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6691424490600716
- 35 USC 102 Novelty (BERT): 0.4982171914535187
- Combined Prediction Score: 0.6520499232994162
- Mean Citation Score: 167.407058
- Max Citation Score: 177.42508
- Similarity Product: 106.6579510653782

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test